Advanced Search
-
Publications
- All Publications
- Books
- Consensus Statements
- Economic Reports
- Environmental Scan
- Evidence Review
-
Health Technology Assessments /
Systematic Reviews - Health Topic Overviews / Scoping Reviews
- HTA Policy
- IHE Discussion Paper
- IHE Roundtable Report
- Journal Articles
- Methodology Papers
- Overview of Systematic Reviews
- Policy Report
- Rapid Reviews
- Statistics Handbooks
- Summary Reports
- News/Events
- General Content
- Adaptation
- Appropriate Use
- Benefits Design
- Cancer
- Cataracts
- Chronic Diseases / Disorders
- Community Health Centres
- Constraints
- COPD
- Core Data Set
- Cost-effectiveness analysis
- COVID-19
- Deliberative Processes
- Diabetes
- Diagnosis
- Diagnostic screening
- Diagonal approach
- Digital Health
- Economic Evaluation
- Effectiveness
- Emergency Care
- Endoscopy
- Epidemiology
- Epidural Steroid Injection
- Extreme Heat Events
- Fetal Alcohol Spectrum Disorder (FASD)
- Funding Models
- Genetic Testing
- Health Data
- Health Economics
- Health Economics / Healthcare Costs
- Health Measurement Tools
- Health Policy
- Health Technology Assessment
- Health Topic Overviews
- Healthcare Services
- Heart Disease
- Heart Failure
- Immunology
- Infection control
- Infectious Diseases
- Innovation
- Life-Cycle
- Low-back pain
- Lumbar Spinal Fusion
- Maternal and Child Health
- Mental Health
- Nurse Practitioners
- Opioid substance use disorder
- Orthopedic
- Other
- Pathology
- Pharmaceutical Policy
- Pharmaceuticals
- Policy Roundtable
- Precision Medicine
- Precision Oncology
- Prevention
- Primary Care
- Priority-Setting
- Psoriasis
- Public Health
- Quality of Life
- Radiofrequency Ablation
- Regulatory Approval
- Reimbursement
- Scoping Reviews
- Screening
- Spillover effects
- Surgery
- Surveillance
- Telehealth
- Therapy
- Uncertainty
- Urgent Care
- Vaccines
- Akpinar, Ilke
- Bond, Ken
- Brown, Jasmine
- Chojecki, Dagmara
- Corabian, Paula
- Guo, Bing
- Harback, Kate
- Institute of Health Economics, IHE
- Kirwin, Erin
- Lopatina, Elena
- McCabe, Christopher
- Moga, Carmen
- Palfrey, Dan
- Pollock, Michelle
- Rafferty, Ellen
- Razavilar, Negar
- Round, Jeff
- Seida, Jennifer
- Sproule, John
- Sutton, Andrew J.
- Tjosvold, Lisa
- Tran, Dat
- Warkentin, Lindsey
- Wright, Erica
- Yan, Charles
The Costs of Industry-Sponsored Drug Trials in Canada
This study, published in PharmacoEconomics – Open, reports exploratory analysis of the provincial and nationwide costs of industry-sponsored drug clinical trials (CTs) in Canada. The costs of industry-sponsored drug CTs completed in 2016 were Can$2.1 billion. In addition to the creation of knowledge, these trials play an important role in alleviating the healthcare cost burden in Canada. Appropriate policy should be in place to foster industry investments in clinical research to advance both scientific and economic merits. This research was funded with an unrestricted grant from Innovative Medicines Canada.
Publication Type: Journal Articles
Year of Publication: 2019
Topics: Health Economics / Healthcare Costs, Pharmaceuticals
Authors: Dat Tran, Ilke Akpinar, Philip Jacobs
Journal Title: PharmacoEconomics - Open